SCHEMBL2864589

SCHEMBL2864589

COc1ccccc1C(=O)NCc1cc2c(-c3cc4ccccc4s3)n[nH]c2cc1F

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 5/20 0.44
ALDH1A1 P00352 5/20 0.43
MAPK1 P28482 3/20 0.43
KDM4E B2RXH2 2/20 0.43
LMNA P02545 2/20 0.43
RAB9A P51151 2/20 0.43
NOD2 Q9HC29 1/20 0.43
GAA P10253 2/20 0.42
NPC1 O15118 2/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
TP53 P04637 2/20 0.42
GLA P06280 1/20 0.42
POLB P06746 2/20 0.42
MAPT P10636 2/20 0.41
HTT P42858 2/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
MAPK10 P53779 1/20 0.40
PLA2G1B P04054 1/20 0.40
ATG4B Q9Y4P1 1/20 0.40
AKR1B1 P15121 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2872606 0.85 SMN1; SMN2 (0.46) HPGDALDH1A1RAB9AGAANPC1
SCHEMBL2861469 0.84 CDK4 (0.48) HPGDALDH1A1MAPK1KDM4ELMNA
SCHEMBL4335941 0.78 MAPT (0.49) HPGDALDH1A1MAPK1KDM4ELMNA
SCHEMBL4341432 0.78 ALDH1A1 (0.47) HPGDALDH1A1MAPK1KDM4ELMNA
SCHEMBL4340978 0.78 ALDH1A1 (0.46) HPGDALDH1A1MAPK1KDM4ELMNA
SCHEMBL2864411 0.76 MAPK10 (0.46) MAPK1MAPK10MAPKAPK2
SCHEMBL4334072 0.76 HPGD (0.47) HPGDALDH1A1MAPK1KDM4ERAB9A
SCHEMBL2862326 0.75 KDM4E (0.46) HPGDALDH1A1KDM4EMAPK10MAPKAPK2
SCHEMBL2870292 0.75 MAPKAPK2 (0.48) MAPK10MAPKAPK2
SCHEMBL6753821 0.75 MAPKAPK2 (0.41) MAPK1RAB9ANPC1MAPK10MAPKAPK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7776890-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-17 US disclosed
US-7776890-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-17 US disclosed
US-7776890-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-17 US disclosed
EP-1380576-B1 1H-INDAZOLE COMPOUNDS INHIBITING JNK EISAI R&D MAN CO LTD (JP) 2009-11-25 EP disclosed
US-20090203691-A1 Novel 1H-indazole compounds OINUMA HITOSHI 2009-08-13 US disclosed
US-20090203691-A1 Novel 1H-indazole compounds OINUMA HITOSHI 2009-08-13 US disclosed
US-20090203691-A1 Novel 1H-indazole compounds OINUMA HITOSHI 2009-08-13 US disclosed
US-7541376-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-02 US disclosed
US-6982274-B2 1H-indazole compound EISAI CO., LTD. (JP) 2006-01-03 US disclosed
US-20050282880-A1 Novel 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2005-12-22 US disclosed
US-20040127538-A1 Novel 1h-indazole compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2004-07-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090203691-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 HPGD 1817/4885ALDH1A1 1588/4885MAPK1 1/4885
US-20040127538-A1 Novel 1h-indazole compound MAPK1, MAPK14, MAPK3 HPGD 1866/4885ALDH1A1 1744/4885MAPK1 1/4885
US-20050282880-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 HPGD 1817/4885ALDH1A1 1588/4885MAPK1 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.